Chen Zhou Selected Research

Chen Zhou Research Topics

Disease

42	Neoplasms (Cancer) 11/2022 - 04/2013
11	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2019
9	Inflammation (Inflammations) 05/2022 - 02/2017
8	Hepatic Encephalopathy 10/2022 - 01/2020
8	Infections 07/2022 - 03/2012
8	Hemorrhage 01/2022 - 02/2019
7	Fibrosis (Cirrhosis) 07/2022 - 12/2019
7	Necrosis 01/2022 - 09/2013
6	Wounds and Injuries (Trauma) 07/2022 - 02/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 04/2017
5	Ascites 10/2022 - 01/2020
5	Liver Neoplasms (Liver Cancer) 04/2022 - 10/2019
5	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2017
4	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 12/2019
4	Hypoxia (Hypoxemia) 01/2022 - 01/2019
4	Portal Hypertension 09/2020 - 12/2019
4	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2020
4	Nasopharyngeal Carcinoma 01/2020 - 01/2019
3	Ischemic Stroke 05/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 04/2022 - 06/2014
3	Sarcopenia 01/2022 - 01/2022
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 04/2006
3	Cardiac Arrhythmias (Arrythmia) 09/2021 - 11/2018
3	Brain Edema (Cerebral Edema) 01/2020 - 04/2006
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 05/2015
3	Lung Neoplasms (Lung Cancer) 03/2019 - 04/2017
3	Ischemia 01/2013 - 04/2006
2	Ulcer 10/2022 - 05/2022
2	Pathologic Constriction (Stenosis) 05/2022 - 04/2010
2	Endoleak 03/2022 - 09/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
2	Reperfusion Injury 01/2022 - 01/2013
2	End Stage Liver Disease 01/2022 - 01/2022
2	Obesity 09/2021 - 01/2020
2	Heart Failure 09/2021 - 07/2021
2	Headache (Headaches) 01/2021 - 08/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2017
2	Varicose Veins (Varicose Vein) 09/2020 - 01/2020
2	Sleep Wake Disorders 04/2020 - 05/2012
2	Rheumatoid Arthritis 01/2020 - 08/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2020
2	Hepatitis B 10/2019 - 03/2012
2	Acute Promyelocytic Leukemia 10/2019 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2019 - 09/2018
2	Insulin Resistance 01/2019 - 02/2013

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2014
8	Pharmaceutical PreparationsIBA 02/2022 - 01/2020
5	RNA (Ribonucleic Acid)IBA 05/2022 - 05/2013
5	AntibodiesIBA 04/2022 - 05/2010
5	apatinibIBA 03/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2018
4	Biological ProductsIBA 01/2021 - 01/2019
4	gadofullereneIBA 01/2021 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2013
4	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2015
4	CytokinesIBA 01/2020 - 06/2011
3	B7-H1 AntigenIBA 04/2022 - 10/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2018
3	Therapeutic UsesIBA 09/2021 - 04/2020
3	SolutionsIBA 09/2021 - 01/2020
3	LipidsIBA 01/2020 - 04/2006
3	GoldIBA 01/2017 - 04/2013
3	Immunoglobulin G (IgG)IBA 05/2013 - 05/2010
2	CollagenIBA 07/2022 - 03/2020
2	Propofol (Diprivan)FDA LinkGeneric 06/2022 - 03/2021
2	Alanine (L-Alanine)FDA Link 05/2022 - 08/2020
2	camrelizumabIBA 03/2022 - 01/2021
2	Coloring Agents (Dyes)IBA 02/2022 - 04/2013
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 10/2010
2	Insulin (Novolin)FDA Link 01/2022 - 01/2019
2	AlbuminsIBA 01/2022 - 10/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 09/2021 - 01/2020
2	AconitineIBA 09/2021 - 07/2021
2	Propranolol (Inderal)FDA LinkGeneric 09/2021 - 07/2021
2	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2021
2	donafenibIBA 01/2021 - 01/2021
2	Angiogenesis InhibitorsIBA 01/2021 - 10/2019
2	Deubiquitinating EnzymesIBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2020 - 07/2011
2	Mitochondrial DNA (mtDNA)IBA 11/2020 - 01/2019
2	EnzymesIBA 01/2020 - 11/2019
2	Iodized OilIBA 01/2020 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 01/2019
2	Anesthetics (Anesthetic Agents)IBA 02/2019 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 12/2018 - 01/2013

Therapy/Procedure

20	Therapeutics 02/2022 - 04/2013
14	Transjugular Intrahepatic Portasystemic Shunt 10/2022 - 12/2019
12	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2022 - 12/2019
9	Drug Therapy (Chemotherapy) 08/2021 - 04/2010
5	Stents 10/2022 - 01/2020
5	Aftercare (After-Treatment) 01/2022 - 09/2013
4	Electroacupuncture 07/2022 - 09/2018
3	Endovascular Aneurysm Repair 10/2022 - 09/2021
3	Splenectomy 10/2022 - 10/2021
3	Radiotherapy 08/2021 - 02/2016
2	Analgesia 03/2021 - 03/2013
2	Immunotherapy 01/2021 - 10/2020
2	Radiofrequency Ablation 01/2020 - 10/2019